N@N

DALLAS--([ BUSINESS WIRE ])--Former United States Securities and Exchange Commission attorney [ Willie Briscoe ] and the securities litigation firm of [ Powers Taylor, LLP ] are continuing their investigation into the sale of Physicians Formula Holdings, Inc. (aPhysicians Formulaa) (NASDAQ: FACE) to Swander Pace Capital for shareholders. On August 15, 2012, Swander Pace agreed to purchase Physicians Formula in a deal valued at approximately $65 million, whereby shareholders would receive $4.25 in cash for each share of Physicians Formula stock owned. However, Physicians Formula announced that it has received a higher unsolicited proposal to acquire all outstanding shares of FACE for $4.90 per share, or $0.65 higher than Swanderas offer. Despite this new offer, Physicians Formula has not changed its recommendation to shareholders.

"Considering that Physicians Formula has received a higher acquisition proposal, the investigation centers on whether the board of directors is adequately considering the deal and attempting to obtain the highest share price for all shareholders."

There is no cost or fee to you, so if you are an affected investor, and you want to learn more about the lawsuit or join the action, contact Patrick Powers at Powers Taylor, LLP, toll free (877) 728-9607, via e-mail at [ patrick@powerstaylor.com ], or Willie Briscoe at The Briscoe Law Firm, PLLC, (214) 706-9314, or via email at [ WBriscoe@TheBriscoeLawFirm.com ].

According to shareholder rights attorney, Willie Briscoe, aConsidering that Physicians Formula has received a higher acquisition proposal, the investigation centers on whether the board of directors is adequately considering the deal and attempting to obtain the highest share price for all shareholders.a

[ The Briscoe Law Firm, PLLC ] is a full service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

[ Powers Taylor, LLP ] is a boutique litigation law firm that handles a variety of complex business litigation matters, including claims of investor and stockholder fraud, shareholder oppression, shareholder derivative suits, and security class actions.